TY - JOUR TI - Tuberculosis innovations mean little if they cannot save lives AU - Pai, Madhukar AU - Furin, Jennifer A2 - Pewsey, Emma VL - 6 PY - 2017 DA - 2017/05/02 SP - e25956 C1 - eLife 2017;6:e25956 DO - 10.7554/eLife.25956 UR - https://doi.org/10.7554/eLife.25956 AB - The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized. KW - tuberculosis KW - diagnostics KW - drugs JF - eLife SN - 2050-084X PB - eLife Sciences Publications, Ltd ER -